Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental You can ward off plenty of health conditions by looking out for early warning signs, but there are no such indications in ...

Topline clinical data of the confirmatory registrational study GLOW2 expected in 1Q 2026. GLOW2 study design mirrors GLOW1 study, which met primary endpoint and ...

Topline clinical data of the confirmatory registrational study GLOW2 expected in 1Q 2026. <li /> GLOW2 study design mirrors GLOW1 study, ...

Q4 2024 Earnings Call Transcript March 5, 2025 EyePoint Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.64 EPS, expectations were $-0.54. Tessa Romero – JPMorgan: Yigal ...

The data was included in the paper, titled “Sozinibercept Combination Therapy for Neovascular Age-Related Macular ...

EyePoint Pharmaceuticals also highlights its state-of-the-art cGMP manufacturing facility in Northbridge, MA, which is ready ...

The associated findings include optic disc pallor and prominent vascular thinning. open_in_new Stage 0 Normal foveal reflex No macular abnormalities are identified Normal foveal anatomy No macular ...

A greater proportion of patients in this subgroup also gained ≥15 letters and had improved anatomy of better drying of the retina with reduced CNV area at week 24 compared to ranibizumab alone.

Baseline angiographic lesion characteristics predictive of clinical response Published in peer-reviewed journal Ophthalmic Surgery, Lasers and Imaging Retina MELBOURNE, Australia and PRINCETON, N.J., ...

Macular degeneration causes vision loss and primarily affects people age 65 and older. The condition affects the macula, the sensitive part of the retina responsible for sharp, central vision. There ...

Although age is the top risk factor for age-related macular degeneration, research shows that genetics play a big part in your risk of developing this eye condition. Our eyes go through several ...